Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
factor-rich plasma
- Development stage
- Unknown
- Lead developer
- Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
- Modality
- Cell Therapies
- Administration
- Intraovarian
01
Overview
Factor-rich plasma (FRP) is an autologous biologic therapy consisting of a concentrated solution of growth factors derived from a patient's own peripheral blood. Developed by the Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz, it is primarily investigated for the treatment of diminished ovarian reserve (DOR) and premature ovarian insufficiency. The preparation involves the activation of platelets to release a cocktail of regenerative proteins, including vascular endothelial growth factor (VEGF), transforming growth factor-beta (TGF-β), and platelet-derived growth factor (PDGF). When injected intraovarianly, FRP is thought to enhance the ovarian microenvironment, promote neoangiogenesis, and stimulate the activation of dormant primordial follicles, potentially improving oocyte yield and pregnancy outcomes in women with low reproductive potential.
- Brand names
- Endoret
- Other names
- Autologous factor-rich plasmaPlasma rich in growth factorsPRGF
Beyond the preview
Go deeper on factor-rich plasma.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on factor-rich plasma.